Elizabeth A. Spencer

Feinstein Institute for Medical Research

Also affiliated with Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Precision Medicine in Pediatric Inflammatory Bowel Disease”.

Precision Medicine in Pediatric Inflammatory Bowel Disease

Pediatric Clinics of North America(2021)10.1016/j.pcl.2021.07.011

N/A

0.425DataRank · unranked

16 citations

Marla C. Dubinsky, Elizabeth A. Spencer

Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients

Inflammatory Bowel Diseases(2021)10.1093/ibd/izab194

N/A

0DataRank · unranked

22 citations

Eyal Klang, Michael T. Dolinger, Nanci Pittman, Marla C. Dubinsky, Elizabeth A. Spencer

Prognostication in inflammatory bowel disease

Frontiers in Medicine(2022)10.3389/fmed.2022.1025375

N/A

0DataRank · unranked

11 citations

Manasi Agrawal, Tine Jess, Elizabeth A. Spencer

Reply

Gastroenterology(2022)10.1053/j.gastro.2022.07.001

N/A

0DataRank · unranked

0 citations

Marla C. Dubinsky, Elizabeth A. Spencer

Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease

Inflammatory Bowel Diseases(2023)10.1093/ibd/izad300

N/A

0DataRank · unranked

43 citations

Suzannah Bergstein, Michael T. Dolinger, Nanci Pittman, Amelia Kellar, David Dunkin +2 more

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.01.005

N/A

0DataRank · unranked

20 citations

Hannah Posner, Elizabeth A. Spencer, Jean‐Frédéric Colombel, Carlos Stalgis, Ryan C. Ungaro +1 more

Barriers to optimizing inflammatory bowel disease care in the United States

Therapeutic Advances in Gastroenterology(2023)10.1177/17562848231169652

N/A

0DataRank · unranked

18 citations

Sadeea Abbasi, Maia Kayal, Elizabeth A. Spencer

Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch

Inflammatory Bowel Diseases(2024)10.1093/ibd/izae164

N/A

0DataRank · unranked

7 citations

Elizabeth A. Spencer, Matthew D. Smyth, Laura E. Raffals, Taha Qazi, Parakkal Deepak +10 more

Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN

Inflammatory Bowel Diseases(2025)10.1093/ibd/izaf166

N/A

0DataRank · unranked

4 citations

Elizabeth A. Spencer, Suzannah Bergstein, Katarína Mitrová, Ondřej Hradský, Matteo Bramuzzo +7 more

Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists

Gastroenterology(2021)10.1053/j.gastro.2021.04.063

N/A

0DataRank · unranked

260 citations

Elizabeth A. Spencer, Jean‐Frédéric Colombel, Ryan C. Ungaro, Manasi Agrawal

Comparable 12-week and Superior 24-week Remission With Risankizumab vs Ustekinumab for Crohn’s-like Disease of the Pouch

Clinical Gastroenterology and Hepatology(2025)10.1016/j.cgh.2025.10.026

N/A

0DataRank · unranked

1 citations

Darwin Jimenez, Justin Huang, Elizabeth A. Spencer, Maia Kayal